Market Outlook
The global Transdermal Drug Patches market size was valued at USD 6850.7 million in 2022 and is forecast to a readjusted size of USD 8516.5 million by 2029 with a CAGR of 3.2% during review period.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
The major players in global Transdermal Drug Patches market include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, etc. The top 3 players occupy about 35% shares of the global market. America and Europe are main markets, they occupy about 75% of the global market. Methyl Salicylate-based Patch is the main type, with a share over 15%. Rx Channel is the main application, which holds a share about 90%.
This report is a detailed and comprehensive analysis for global Transdermal Drug Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Transdermal Drug Patches market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/Pc), 2018-2029
Global Transdermal Drug Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/Pc), 2018-2029
Global Transdermal Drug Patches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/Pc), 2018-2029
Global Transdermal Drug Patches market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (US$/Pc), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transdermal Drug Patches
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transdermal Drug Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segmentation By Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segmentation By Application
Rx Channel
OTC Channel
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Transdermal Drug Patches Market in 2025?
Transdermal drug patches offer the advantage of continuous drug delivery, which enhances therapeutic efficacy and patient compliance. Their non-invasive nature and ease of use make them appealing, especially for chronic disease management. Additionally, their ability to provide controlled release and bypass the digestive system can reduce side effects, leading to more targeted treatment.
What are the weaknesses of the Transdermal Drug Patches Market in 2025?
The market faces challenges such as skin irritation or allergic reactions at the patch site, limiting its usability for some patients. Moreover, the absorption rate can vary depending on the drug, skin type, and environmental conditions, which may affect the consistency of treatment. Limited drug options for transdermal delivery also hinder its full potential.
What are the opportunities in the Transdermal Drug Patches Market in 2025?
The growing demand for non-invasive treatment options presents significant opportunities for market expansion. Advances in technology could lead to more drugs being suitable for transdermal delivery. Additionally, rising awareness of the benefits of patient compliance and convenience, particularly in elderly populations, is driving the market forward. Integration with digital health monitoring could further expand the market's reach.
What are the threats to the Transdermal Drug Patches Market in 2025?
Competitive threats from alternative drug delivery systems, like oral formulations and injectables, pose challenges. Regulatory hurdles and the slow pace of approval for new drugs in patch form also present barriers. Additionally, market fragmentation and the high cost of developing transdermal patches could limit growth, especially in developing regions.
Market PESTEL Analysis
What are the political factors affecting the Transdermal Drug Patches Market in 2025?
Government regulations and policies around healthcare products, including drug delivery systems, play a critical role in shaping the market. Stringent approval processes and safety standards set by regulatory bodies such as the FDA can either facilitate or delay market entry for new transdermal patches. Additionally, political stability in key markets impacts manufacturing and distribution.
What are the economic factors affecting the Transdermal Drug Patches Market in 2025?
Economic factors, such as the affordability of healthcare and the spending power of patients, influence the market. In developed economies, high demand for advanced medical solutions supports market growth, while in emerging markets, economic constraints may limit access to premium drug delivery systems. The cost of production and the pricing of transdermal patches are also influenced by raw material availability and labor costs.
What are the social factors affecting the Transdermal Drug Patches Market in 2025?
An aging global population and the increasing prevalence of chronic diseases drive the demand for more convenient and long-term treatment solutions, like transdermal drug patches. The societal trend toward self-management of health and a preference for non-invasive treatment methods also promotes market growth. Additionally, growing health awareness among consumers boosts interest in innovative drug delivery systems.
What are the technological factors affecting the Transdermal Drug Patches Market in 2025?
Technological advancements in drug delivery systems, such as smart patches with integrated sensors and micro-needles, enhance the effectiveness and monitoring of transdermal patches. Research into new materials and methods for controlled and sustained release of medications also drives innovation. However, there is a constant need for technology upgrades to improve the stability and absorption efficiency of transdermal patches.
What are the environmental factors affecting the Transdermal Drug Patches Market in 2025?
Increasing concerns over sustainability and environmental impact push the market toward eco-friendly materials and production processes. Packaging waste from drug patches and their disposal can be an issue, prompting companies to explore biodegradable or recyclable options. Environmental regulations related to manufacturing and chemical usage may also affect market dynamics.
What are the legal factors affecting the Transdermal Drug Patches Market in 2025?
Legal issues, including intellectual property rights and patent laws, can influence market competition and innovation. Regulatory requirements for product safety and efficacy, along with liability concerns over side effects or failures of drug patches, shape market strategies. Legal frameworks governing the approval and marketing of pharmaceutical products also play a significant role in determining the success of transdermal drug patches.
Market SIPOC Analysis
Who are the suppliers in the Transdermal Drug Patches Market in 2025?
Suppliers include raw material providers for patch components, such as adhesives, drug carriers, and polymers, as well as manufacturers of the active pharmaceutical ingredients (APIs) used in the patches. Additionally, specialized suppliers provide technology for patch design, manufacturing equipment, and regulatory compliance services to ensure the products meet industry standards.
What are the inputs required for the Transdermal Drug Patches Market in 2025?
The inputs for this market include high-quality raw materials like active pharmaceutical ingredients, polymers, and adhesives. Technological inputs, such as research and development resources for new drug delivery technologies, along with compliance data and manufacturing infrastructure, are also essential. Clinical trials data and regulatory approvals are vital inputs to ensure product efficacy and safety.
What are the processes involved in the Transdermal Drug Patches Market in 2025?
The processes include the research and development of new transdermal drug formulations, design and production of the patches, and rigorous testing for quality assurance and regulatory approval. The manufacturing process involves combining the active ingredient with delivery systems, followed by packaging, distribution, and post-market surveillance to monitor product performance and address any issues.
Who are the customers in the Transdermal Drug Patches Market in 2025?
The customers are healthcare providers, including hospitals, clinics, and pharmacies, as well as patients who directly benefit from the convenience of transdermal drug patches. Additionally, pharmaceutical companies and medical device distributors are key customers for transdermal patch manufacturers. The elderly and patients with chronic conditions, who require continuous medication, form a significant customer base.
What are the outputs in the Transdermal Drug Patches Market in 2025?
The primary outputs are transdermal drug patches, which are available in various formulations for the treatment of chronic diseases, pain management, hormone replacement therapy, and more. The outputs also include clinical reports and regulatory-compliant documentation that confirm the efficacy, safety, and quality of the patches.
Market Porter's Five Forces
What is the threat of new entrants in the Transdermal Drug Patches Market in 2025?
The threat of new entrants is moderate. While the barriers to entry, such as research and development costs, regulatory approval, and the need for specialized manufacturing facilities, are significant, advancements in technology and growing demand for transdermal drug delivery systems make the market attractive. However, established players with brand recognition and regulatory expertise still hold a competitive advantage.
What is the bargaining power of suppliers in the Transdermal Drug Patches Market in 2025?
The bargaining power of suppliers is moderate. The suppliers of raw materials like polymers, adhesives, and active pharmaceutical ingredients have some influence, but as the market grows, manufacturers may have multiple options to source materials. Additionally, innovation in materials and manufacturing techniques can help reduce supplier power, as alternative sources become more available.
What is the bargaining power of buyers in the Transdermal Drug Patches Market in 2025?
The bargaining power of buyers is high. Healthcare providers and patients can choose from a range of treatment options, including oral medications, injectables, and other drug delivery systems. As the market for transdermal patches grows, patients demand more cost-effective and efficient solutions, which forces companies to innovate and maintain competitive pricing to retain customer loyalty.
What is the threat of substitutes in the Transdermal Drug Patches Market in 2025?
The threat of substitutes is moderate. While transdermal drug patches offer unique benefits, such as controlled release and ease of use, alternatives like oral medications, injections, and inhalers can serve similar purposes. However, with the increasing preference for non-invasive treatments, the threat of substitutes is somewhat reduced, especially for patients with chronic conditions who require long-term management.
What is the intensity of competitive rivalry in the Transdermal Drug Patches Market in 2025?
The intensity of competitive rivalry is high. As demand for innovative drug delivery systems increases, several companies are entering the market and striving to differentiate their products through improved formulations, new technology, and enhanced patient compliance. The presence of established players and increasing market fragmentation also raises the level of competition.
Market Upstream Analysis
What are the key raw materials involved in the Transdermal Drug Patches Market in 2025?
The key raw materials include active pharmaceutical ingredients (APIs), adhesive polymers, backing layers, and drug release membranes. These materials must meet high-quality standards to ensure the efficacy, safety, and comfort of the patches. Additionally, specialized materials like microneedles and smart sensors are becoming more common in advanced transdermal systems.
How do suppliers impact the Transdermal Drug Patches Market in 2025?
Suppliers play a crucial role by providing the essential raw materials and components that enable the production of transdermal patches. As the market evolves, suppliers of advanced materials and technologies, such as biodegradable polymers or nanomaterials, will have increasing influence on innovation and the ability to meet market demand for more efficient, user-friendly patches.
What are the challenges faced by suppliers in the Transdermal Drug Patches Market in 2025?
Suppliers face challenges related to the consistent quality and supply of specialized materials, as transdermal drug patches require highly specific ingredients to work effectively. Volatility in the prices of raw materials, like certain polymers or APIs, can disrupt the supply chain. Regulatory compliance and the need for continuous innovation to match industry standards also create additional pressure on suppliers.
How does the regulatory environment affect the upstream processes of the Transdermal Drug Patches Market in 2025?
Regulatory requirements heavily impact upstream processes by ensuring that suppliers and manufacturers adhere to strict quality control standards for the materials used in drug patches. Obtaining regulatory approval for new materials or technologies can be time-consuming and expensive, and any delays in the approval process can affect the overall supply chain for transdermal patches.
What role does technology play in the upstream supply chain of the Transdermal Drug Patches Market in 2025?
Technology is essential for improving the efficiency of raw material sourcing, production processes, and quality control in the upstream supply chain. Innovations like automated manufacturing systems and advanced testing technologies ensure high-quality production and faster time-to-market. The integration of smart technologies in materials, such as micro-sensors or controlled release mechanisms, also influences upstream processes by requiring suppliers to adapt to new production capabilities.
Market Midstream Analysis
What are the key processes involved in the midstream phase of the Transdermal Drug Patches Market in 2025?
The midstream phase primarily involves the manufacturing and assembly of transdermal drug patches. This includes the formulation of the drug, the integration of active ingredients with delivery systems, and the development of various layers such as the adhesive, backing, and drug-releasing membranes. Additionally, quality control processes, regulatory compliance, and packaging are essential to ensure the final product meets safety and efficacy standards.
How do manufacturers impact the Transdermal Drug Patches Market in 2025?
Manufacturers directly impact the market by determining the quality, innovation, and cost-efficiency of transdermal drug patches. They are responsible for the production scale, technology integration, and the ability to adapt to evolving healthcare needs, such as personalized medicine or smart patches. Manufacturers' decisions regarding production techniques and sourcing also affect market availability and pricing.
What are the challenges manufacturers face in the midstream phase of the Transdermal Drug Patches Market in 2025?
Manufacturers face challenges such as maintaining high product quality while managing production costs. Regulatory compliance is another key issue, as drug delivery systems must meet stringent safety and performance standards. Additionally, there is a need to constantly innovate and improve patch design, such as enhancing the drug absorption rate and minimizing skin irritation, which adds complexity to manufacturing.
How does technology influence the midstream processes of the Transdermal Drug Patches Market in 2025?
Technology plays a critical role by enabling more efficient and precise manufacturing processes. The use of automation and advanced robotics improves production speed while ensuring high-quality standards. Furthermore, innovations such as smart transdermal patches with embedded sensors or micro-needles require cutting-edge technology for design and production, pushing manufacturers to invest in new capabilities and equipment.
What role does distribution play in the midstream of the Transdermal Drug Patches Market in 2025?
Distribution is essential in ensuring that transdermal drug patches reach the right healthcare providers and patients. Efficient logistics and supply chain management are key to ensuring timely delivery to pharmacies, hospitals, and clinics. Distribution also involves navigating complex regulations in various regions, which can affect the speed and cost of bringing products to market.
Market Downstream Analysis
What are the key activities in the downstream phase of the Transdermal Drug Patches Market in 2025?
The downstream phase primarily involves the distribution, marketing, and use of transdermal drug patches by healthcare providers and patients. This includes placing the patches on the market through pharmacies, hospitals, and clinics, educating healthcare professionals on their benefits and usage, and ensuring effective patient engagement for adherence to prescribed treatments.
How do healthcare providers influence the Transdermal Drug Patches Market in 2025?
Healthcare providers play a significant role by recommending and prescribing transdermal drug patches to patients. Their ability to educate patients about the advantages of transdermal drug delivery, such as convenience and fewer side effects, directly influences patient adoption. Providers' trust in the product's efficacy and safety also impacts market growth, as they are key decision-makers in treatment plans.
What challenges do patients face in the downstream phase of the Transdermal Drug Patches Market in 2025?
Patients may face challenges such as skin irritation or allergies from prolonged patch use, which could deter long-term adherence. Additionally, the cost of the patches may be prohibitive for some patients, especially in developing markets. Education about proper usage, including when and how to apply the patch for maximum effectiveness, is also a common challenge that can affect patient outcomes.
How does marketing impact the downstream phase of the Transdermal Drug Patches Market in 2025?
Marketing is crucial in raising awareness about the benefits of transdermal drug patches, educating both healthcare professionals and patients. Effective marketing strategies help differentiate products in a competitive market, showcasing innovations like improved patch designs or added features such as digital integration. Strong marketing campaigns can drive demand and influence prescription patterns, especially for chronic conditions.
How do regulatory and reimbursement policies affect the downstream phase of the Transdermal Drug Patches Market in 2025?
Regulatory and reimbursement policies directly affect the accessibility and affordability of transdermal drug patches. Reimbursement schemes influence patient access, with insurance coverage determining whether patients can afford these treatments. Regulatory approval processes also impact how quickly and widely these patches can be distributed, affecting their availability in different regions and markets.
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches from 2018 to 2023.
Chapter 3, the Transdermal Drug Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Drug Patches.
Chapter 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Transdermal Drug Patches
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Transdermal Drug Patches Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Methyl Salicylate-based Patch
1.3.3 Rivastigmine Transdermal Patch
1.3.4 Fentanyl Transdermal Patch
1.3.5 Lidocaine Patch
1.3.6 Diclofenac Patch
1.3.7 Nicotine Transdermal Patch
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Transdermal Drug Patches Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Rx Channel
1.4.3 OTC Channel
1.5 Global Transdermal Drug Patches Market Size & Forecast
1.5.1 Global Transdermal Drug Patches Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Transdermal Drug Patches Sales Quantity (2018-2029)
1.5.3 Global Transdermal Drug Patches Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
2.2.4 Johnson & Johnson Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Transdermal Drug Patches Product and Services
2.3.4 Novartis Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments/Updates
2.4 UCB Pharma
2.4.1 UCB Pharma Details
2.4.2 UCB Pharma Major Business
2.4.3 UCB Pharma Transdermal Drug Patches Product and Services
2.4.4 UCB Pharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 UCB Pharma Recent Developments/Updates
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Transdermal Drug Patches Product and Services
2.5.4 Mylan Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Mylan Recent Developments/Updates
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
2.6.4 Teva Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Recent Developments/Updates
2.7 Nitto Denko
2.7.1 Nitto Denko Details
2.7.2 Nitto Denko Major Business
2.7.3 Nitto Denko Transdermal Drug Patches Product and Services
2.7.4 Nitto Denko Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nitto Denko Recent Developments/Updates
2.8 Grünenthal
2.8.1 Grünenthal Details
2.8.2 Grünenthal Major Business
2.8.3 Grünenthal Transdermal Drug Patches Product and Services
2.8.4 Grünenthal Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Grünenthal Recent Developments/Updates
2.9 IBSA Group
2.9.1 IBSA Group Details
2.9.2 IBSA Group Major Business
2.9.3 IBSA Group Transdermal Drug Patches Product and Services
2.9.4 IBSA Group Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 IBSA Group Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Transdermal Drug Patches Product and Services
2.10.4 GSK Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GSK Recent Developments/Updates
2.11 Luye Pharma Group
2.11.1 Luye Pharma Group Details
2.11.2 Luye Pharma Group Major Business
2.11.3 Luye Pharma Group Transdermal Drug Patches Product and Services
2.11.4 Luye Pharma Group Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Luye Pharma Group Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Transdermal Drug Patches Product and Services
2.12.4 Pfizer Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pfizer Recent Developments/Updates
2.13 Chattem
2.13.1 Chattem Details
2.13.2 Chattem Major Business
2.13.3 Chattem Transdermal Drug Patches Product and Services
2.13.4 Chattem Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Chattem Recent Developments/Updates
2.14 Dr Reddy’s Laboratories
2.14.1 Dr Reddy’s Laboratories Details
2.14.2 Dr Reddy’s Laboratories Major Business
2.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
2.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Transdermal Drug Patches Product and Services
2.15.4 Bayer Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Bayer Recent Developments/Updates
2.16 Mundipharma
2.16.1 Mundipharma Details
2.16.2 Mundipharma Major Business
2.16.3 Mundipharma Transdermal Drug Patches Product and Services
2.16.4 Mundipharma Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Mundipharma Recent Developments/Updates
2.17 Endo International
2.17.1 Endo International Details
2.17.2 Endo International Major Business
2.17.3 Endo International Transdermal Drug Patches Product and Services
2.17.4 Endo International Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Endo International Recent Developments/Updates
2.18 Beijing Tide Pharmaceutical
2.18.1 Beijing Tide Pharmaceutical Details
2.18.2 Beijing Tide Pharmaceutical Major Business
2.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
2.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Transdermal Drug Patches by Manufacturer
3.1 Global Transdermal Drug Patches Sales Quantity by Manufacturer (2018-2023)
3.2 Global Transdermal Drug Patches Revenue by Manufacturer (2018-2023)
3.3 Global Transdermal Drug Patches Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Transdermal Drug Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2022
3.4.2 Top 6 Transdermal Drug Patches Manufacturer Market Share in 2022
3.5 Transdermal Drug Patches Market: Overall Company Footprint Analysis
3.5.1 Transdermal Drug Patches Market: Region Footprint
3.5.2 Transdermal Drug Patches Market: Company Product Type Footprint
3.5.3 Transdermal Drug Patches Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Transdermal Drug Patches Market Size by Region
4.1.1 Global Transdermal Drug Patches Sales Quantity by Region (2018-2029)
4.1.2 Global Transdermal Drug Patches Consumption Value by Region (2018-2029)
4.1.3 Global Transdermal Drug Patches Average Price by Region (2018-2029)
4.2 North America Transdermal Drug Patches Consumption Value (2018-2029)
4.3 Europe Transdermal Drug Patches Consumption Value (2018-2029)
4.4 Asia-Pacific Transdermal Drug Patches Consumption Value (2018-2029)
4.5 South America Transdermal Drug Patches Consumption Value (2018-2029)
4.6 Middle East and Africa Transdermal Drug Patches Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Transdermal Drug Patches Sales Quantity by Type (2018-2029)
5.2 Global Transdermal Drug Patches Consumption Value by Type (2018-2029)
5.3 Global Transdermal Drug Patches Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Transdermal Drug Patches Sales Quantity by Application (2018-2029)
6.2 Global Transdermal Drug Patches Consumption Value by Application (2018-2029)
6.3 Global Transdermal Drug Patches Average Price by Application (2018-2029)
7 North America
7.1 North America Transdermal Drug Patches Sales Quantity by Type (2018-2029)
7.2 North America Transdermal Drug Patches Sales Quantity by Application (2018-2029)
7.3 North America Transdermal Drug Patches Market Size by Country
7.3.1 North America Transdermal Drug Patches Sales Quantity by Country (2018-2029)
7.3.2 North America Transdermal Drug Patches Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Transdermal Drug Patches Sales Quantity by Type (2018-2029)
8.2 Europe Transdermal Drug Patches Sales Quantity by Application (2018-2029)
8.3 Europe Transdermal Drug Patches Market Size by Country
8.3.1 Europe Transdermal Drug Patches Sales Quantity by Country (2018-2029)
8.3.2 Europe Transdermal Drug Patches Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Transdermal Drug Patches Market Size by Region
9.3.1 Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Transdermal Drug Patches Sales Quantity by Type (2018-2029)
10.2 South America Transdermal Drug Patches Sales Quantity by Application (2018-2029)
10.3 South America Transdermal Drug Patches Market Size by Country
10.3.1 South America Transdermal Drug Patches Sales Quantity by Country (2018-2029)
10.3.2 South America Transdermal Drug Patches Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Transdermal Drug Patches Market Size by Country
11.3.1 Middle East & Africa Transdermal Drug Patches Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Transdermal Drug Patches Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Transdermal Drug Patches Market Drivers
12.2 Transdermal Drug Patches Market Restraints
12.3 Transdermal Drug Patches Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Transdermal Drug Patches and Key Manufacturers
13.2 Manufacturing Costs Percentage of Transdermal Drug Patches
13.3 Transdermal Drug Patches Production Process
13.4 Transdermal Drug Patches Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Transdermal Drug Patches Typical Distributors
14.3 Transdermal Drug Patches Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Transdermal Drug Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Pharmaceutical Major Business
Table 5. Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
Table 6. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Transdermal Drug Patches Product and Services
Table 11. Johnson & Johnson Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Transdermal Drug Patches Product and Services
Table 16. Novartis Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 19. UCB Pharma Major Business
Table 20. UCB Pharma Transdermal Drug Patches Product and Services
Table 21. UCB Pharma Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. UCB Pharma Recent Developments/Updates
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Transdermal Drug Patches Product and Services
Table 26. Mylan Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Mylan Recent Developments/Updates
Table 28. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Major Business
Table 30. Teva Pharmaceutical Transdermal Drug Patches Product and Services
Table 31. Teva Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharmaceutical Recent Developments/Updates
Table 33. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 34. Nitto Denko Major Business
Table 35. Nitto Denko Transdermal Drug Patches Product and Services
Table 36. Nitto Denko Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Nitto Denko Recent Developments/Updates
Table 38. Grünenthal Basic Information, Manufacturing Base and Competitors
Table 39. Grünenthal Major Business
Table 40. Grünenthal Transdermal Drug Patches Product and Services
Table 41. Grünenthal Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Grünenthal Recent Developments/Updates
Table 43. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 44. IBSA Group Major Business
Table 45. IBSA Group Transdermal Drug Patches Product and Services
Table 46. IBSA Group Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. IBSA Group Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Transdermal Drug Patches Product and Services
Table 51. GSK Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GSK Recent Developments/Updates
Table 53. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 54. Luye Pharma Group Major Business
Table 55. Luye Pharma Group Transdermal Drug Patches Product and Services
Table 56. Luye Pharma Group Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Luye Pharma Group Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Transdermal Drug Patches Product and Services
Table 61. Pfizer Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Pfizer Recent Developments/Updates
Table 63. Chattem Basic Information, Manufacturing Base and Competitors
Table 64. Chattem Major Business
Table 65. Chattem Transdermal Drug Patches Product and Services
Table 66. Chattem Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Chattem Recent Developments/Updates
Table 68. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 69. Dr Reddy’s Laboratories Major Business
Table 70. Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
Table 71. Dr Reddy’s Laboratories Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Dr Reddy’s Laboratories Recent Developments/Updates
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Transdermal Drug Patches Product and Services
Table 76. Bayer Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bayer Recent Developments/Updates
Table 78. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 79. Mundipharma Major Business
Table 80. Mundipharma Transdermal Drug Patches Product and Services
Table 81. Mundipharma Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Mundipharma Recent Developments/Updates
Table 83. Endo International Basic Information, Manufacturing Base and Competitors
Table 84. Endo International Major Business
Table 85. Endo International Transdermal Drug Patches Product and Services
Table 86. Endo International Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Endo International Recent Developments/Updates
Table 88. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Beijing Tide Pharmaceutical Major Business
Table 90. Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
Table 91. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Quantity (M Pcs), Average Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 93. Global Transdermal Drug Patches Sales Quantity by Manufacturer (2018-2023) & (M Pcs)
Table 94. Global Transdermal Drug Patches Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Transdermal Drug Patches Average Price by Manufacturer (2018-2023) & (US$/Pc)
Table 96. Market Position of Manufacturers in Transdermal Drug Patches, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
Table 98. Transdermal Drug Patches Market: Company Product Type Footprint
Table 99. Transdermal Drug Patches Market: Company Product Application Footprint
Table 100. Transdermal Drug Patches New Market Entrants and Barriers to Market Entry
Table 101. Transdermal Drug Patches Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Transdermal Drug Patches Sales Quantity by Region (2018-2023) & (M Pcs)
Table 103. Global Transdermal Drug Patches Sales Quantity by Region (2024-2029) & (M Pcs)
Table 104. Global Transdermal Drug Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Transdermal Drug Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Transdermal Drug Patches Average Price by Region (2018-2023) & (US$/Pc)
Table 107. Global Transdermal Drug Patches Average Price by Region (2024-2029) & (US$/Pc)
Table 108. Global Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pcs)
Table 109. Global Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pcs)
Table 110. Global Transdermal Drug Patches Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Transdermal Drug Patches Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Transdermal Drug Patches Average Price by Type (2018-2023) & (US$/Pc)
Table 113. Global Transdermal Drug Patches Average Price by Type (2024-2029) & (US$/Pc)
Table 114. Global Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pcs)
Table 115. Global Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pcs)
Table 116. Global Transdermal Drug Patches Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Transdermal Drug Patches Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Transdermal Drug Patches Average Price by Application (2018-2023) & (US$/Pc)
Table 119. Global Transdermal Drug Patches Average Price by Application (2024-2029) & (US$/Pc)
Table 120. North America Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pcs)
Table 121. North America Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pcs)
Table 122. North America Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pcs)
Table 123. North America Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pcs)
Table 124. North America Transdermal Drug Patches Sales Quantity by Country (2018-2023) & (M Pcs)
Table 125. North America Transdermal Drug Patches Sales Quantity by Country (2024-2029) & (M Pcs)
Table 126. North America Transdermal Drug Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Transdermal Drug Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pcs)
Table 129. Europe Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pcs)
Table 130. Europe Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pcs)
Table 131. Europe Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pcs)
Table 132. Europe Transdermal Drug Patches Sales Quantity by Country (2018-2023) & (M Pcs)
Table 133. Europe Transdermal Drug Patches Sales Quantity by Country (2024-2029) & (M Pcs)
Table 134. Europe Transdermal Drug Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Transdermal Drug Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pcs)
Table 137. Asia-Pacific Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pcs)
Table 138. Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pcs)
Table 139. Asia-Pacific Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pcs)
Table 140. Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2018-2023) & (M Pcs)
Table 141. Asia-Pacific Transdermal Drug Patches Sales Quantity by Region (2024-2029) & (M Pcs)
Table 142. Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Transdermal Drug Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pcs)
Table 145. South America Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pcs)
Table 146. South America Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pcs)
Table 147. South America Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pcs)
Table 148. South America Transdermal Drug Patches Sales Quantity by Country (2018-2023) & (M Pcs)
Table 149. South America Transdermal Drug Patches Sales Quantity by Country (2024-2029) & (M Pcs)
Table 150. South America Transdermal Drug Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Transdermal Drug Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2018-2023) & (M Pcs)
Table 153. Middle East & Africa Transdermal Drug Patches Sales Quantity by Type (2024-2029) & (M Pcs)
Table 154. Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2018-2023) & (M Pcs)
Table 155. Middle East & Africa Transdermal Drug Patches Sales Quantity by Application (2024-2029) & (M Pcs)
Table 156. Middle East & Africa Transdermal Drug Patches Sales Quantity by Region (2018-2023) & (M Pcs)
Table 157. Middle East & Africa Transdermal Drug Patches Sales Quantity by Region (2024-2029) & (M Pcs)
Table 158. Middle East & Africa Transdermal Drug Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Transdermal Drug Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Transdermal Drug Patches Raw Material
Table 161. Key Manufacturers of Transdermal Drug Patches Raw Materials
Table 162. Transdermal Drug Patches Typical Distributors
Table 163. Transdermal Drug Patches Typical Customers
List of Figures
Figure 1. Transdermal Drug Patches Picture
Figure 2. Global Transdermal Drug Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Transdermal Drug Patches Consumption Value Market Share by Type in 2022
Figure 4. Methyl Salicylate-based Patch Examples
Figure 5. Rivastigmine Transdermal Patch Examples
Figure 6. Fentanyl Transdermal Patch Examples
Figure 7. Lidocaine Patch Examples
Figure 8. Diclofenac Patch Examples
Figure 9. Nicotine Transdermal Patch Examples
Figure 10. Others Examples
Figure 11. Global Transdermal Drug Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 12. Global Transdermal Drug Patches Consumption Value Market Share by Application in 2022
Figure 13. Rx Channel Examples
Figure 14. OTC Channel Examples
Figure 15. Global Transdermal Drug Patches Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Transdermal Drug Patches Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Transdermal Drug Patches Sales Quantity (2018-2029) & (M Pcs)
Figure 18. Global Transdermal Drug Patches Average Price (2018-2029) & (US$/Pc)
Figure 19. Global Transdermal Drug Patches Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Transdermal Drug Patches Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Transdermal Drug Patches by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Transdermal Drug Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Transdermal Drug Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Transdermal Drug Patches Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Transdermal Drug Patches Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Transdermal Drug Patches Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Transdermal Drug Patches Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Transdermal Drug Patches Average Price by Type (2018-2029) & (US$/Pc)
Figure 34. Global Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Transdermal Drug Patches Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Transdermal Drug Patches Average Price by Application (2018-2029) & (US$/Pc)
Figure 37. North America Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Transdermal Drug Patches Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Transdermal Drug Patches Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Transdermal Drug Patches Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Transdermal Drug Patches Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Transdermal Drug Patches Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Transdermal Drug Patches Consumption Value Market Share by Region (2018-2029)
Figure 57. China Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Transdermal Drug Patches Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Transdermal Drug Patches Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Transdermal Drug Patches Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Transdermal Drug Patches Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Transdermal Drug Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Transdermal Drug Patches Market Drivers
Figure 78. Transdermal Drug Patches Market Restraints
Figure 79. Transdermal Drug Patches Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Transdermal Drug Patches in 2022
Figure 82. Manufacturing Process Analysis of Transdermal Drug Patches
Figure 83. Transdermal Drug Patches Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
